Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
British Journal of Haematology
|
December 2, 2017
"Mouse-MRD" in central nervous system acute lymphoblastic leukaemia: assessing bone marrow minimal residual disease using a xenograft model - from bedside to the bench and back again
Julia Alten, Alexander Claviez, Simon Vieth, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
January 29, 2010
Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein
Leo Veenman, Julia Alten, Karen Linnemannstöns, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 8, 2021
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
Christian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, et al.
Pediatric Blood & Cancer
|
November 19, 2019
Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients
Matthias Bleeke, Pascal Johann, Susanne Gröbner, et al.
Pediatric Blood & Cancer
|
October 28, 2016
DNA methylation profiling of pediatric B-cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites
Anke K Bergmann, Giancarlo Castellano, Julia Alten, et al.
Journal of Cellular and Molecular Medicine
|
September 27, 2023
XBP1 promotes NRAS<sup>G12D</sup> pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS
Azam Salimi, Mirle Schemionek-Reinders, Michael Huber, et al.
British Journal of Haematology
|
March 25, 2024
Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009
Anke Barnbrock, Anja Möricke, Draga Barbaric, et al.
Haematologica
|
July 11, 2019
<i>TP53, ETV6</i> and <i>RUNX1</i> germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia
Stefanie V Junk, Norman Klein, Sabine Schreek, et al.
Pediatric Blood & Cancer
|
April 3, 2015
Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia
Julia Alten, Wolfram Klapper, Ivo Leuschner, et al.
Genes, Chromosomes & Cancer
|
June 28, 2020
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol
Mareike Jung, Maximilian Schieck, Winfried Hofmann, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
British Journal of Haematology
|
December 2, 2017
"Mouse-MRD" in central nervous system acute lymphoblastic leukaemia: assessing bone marrow minimal residual disease using a xenograft model - from bedside to the bench and back again
Julia Alten, Alexander Claviez, Simon Vieth, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
January 29, 2010
Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein
Leo Veenman, Julia Alten, Karen Linnemannstöns, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 8, 2021
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
Christian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, et al.
Pediatric Blood & Cancer
|
November 19, 2019
Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients
Matthias Bleeke, Pascal Johann, Susanne Gröbner, et al.
Pediatric Blood & Cancer
|
October 28, 2016
DNA methylation profiling of pediatric B-cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites
Anke K Bergmann, Giancarlo Castellano, Julia Alten, et al.
Journal of Cellular and Molecular Medicine
|
September 27, 2023
XBP1 promotes NRAS<sup>G12D</sup> pre-B acute lymphoblastic leukaemia through IL-7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS
Azam Salimi, Mirle Schemionek-Reinders, Michael Huber, et al.
British Journal of Haematology
|
March 25, 2024
Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009
Anke Barnbrock, Anja Möricke, Draga Barbaric, et al.
Haematologica
|
July 11, 2019
<i>TP53, ETV6</i> and <i>RUNX1</i> germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia
Stefanie V Junk, Norman Klein, Sabine Schreek, et al.
Pediatric Blood & Cancer
|
April 3, 2015
Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia
Julia Alten, Wolfram Klapper, Ivo Leuschner, et al.
Genes, Chromosomes & Cancer
|
June 28, 2020
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol
Mareike Jung, Maximilian Schieck, Winfried Hofmann, et al.
Page
of 4